The entire process from discovering and developing a potential drug candidate to its delivery into the human body requires comprehensive knowledge about the root cause
of the disease at molecular, cellular and genetic levels, and can be a costly and long-term process. Nevertheless, Danish biotech and pharma companies are still among the best in Europe when it comes to drug development and innovation. However, Dr Rasmus Beedholm-Ebsen at Invest in Denmark argues it is important to look into new methods in order to discover and develop new drugs, and to have an innovative approach when it comes to drug delivery.